Abstract:Abstract Background Post-acute sequelae of COVID-19 [PASC] is thought to occur in 10% of all COVID infections and has previously been associated with autonomic dysfunction including postural orthostatic tachycardia syndrome [POTS].[1,2] Purpose To assess prevalence of autonomic disorders in those with PASC. Methods Consecutive patients reporting unexplained symptoms persisting for ≥3 months after SARS-CoV-2 infection were recruited through social media platforms. Beat to beat plethysmography was used to determine autonomic haemodynamic response to 10-minute active stand test, Valsalva maneuverer and deep breathing. International criteria were used to diagnose POTS, initial orthostatic hypotension (IOH), and classical orthostatic hypotension (COH). Validated patient reported outcome measures were used to determine symptom severity and health related quality of life (HrQoL) including, composite autonomic symptom score [COMPASS-31], Euroquol 5-Dimension [EQ-5D] and fatigue severity score (FSS). Results Institutional ethics was granted from our university. A total of 150 PASC participants (79% female, 93% Caucasian) with a mean age of 40.7 ± 11.5 years and BMI 25.8 ± 6.7 were prospectively consented and enrolled. In total 86% were vaccinated with at least 2 vaccines at the time of acute SARS-CoV-2 infection. The mean time to onset of PASC symptoms after acute infection was 18.3 ± 35.3 days and duration of symptoms at time of testing was 306.9 ± 188.1 days. In total 75% of participants met the criteria for an autonomic disorder with the most common diagnoses being POTS (55%), initial orthostatic hypotension (38%), and classic orthostatic hypotension (5%) respectively. Valsalva ratio was within normal limits for the majority (90%) of participants however it was statistically higher in those with POTS compared to those without (1.9±.6 versus 1.7±.8: p=.014). Total composite autonomic symptoms were more severe in women than men (42.6±13.1 vs. 35.4±19.9; p = .018) and those with a COMPASS-31 score >40 (49%) had worse fatigue severity (57.9±6.9 vs. 50.3±14.3: p<.001) and poorer EQ-5D utility health scores (0.611±0.247 vs 0.701±0.237: p =.008) on a scale from 0-1 where ‘1’ = ‘full health’. The mean FSS score was 53.9±11.8 out of a maximum score of 63 and fatigue was universally problematic with 92% experiencing FSS score >36. Participants reported only being a mean of 40.5%±21.2% of their previous health status and the mean self-reported ‘health today’ [100 = ‘full health’] was 40.5 ± 14.2. A significant 91.3% reported missing work due to symptoms in the last month and 50.3% had been unable to return to work due to PASC symptoms. Conclusion Autonomic disorders are prevalent in PASC and greatly impact on working capacity and health related quality of life. We call for routine autonomic testing in PASC and further research to explore efficacy of autonomic treatment modalities in this cohort.

Comorbid anxiety is associated with more changes in the Management of Postural Orthostatic Tachycardia Syndrome

Factors associated with initiation of pharmacological therapy and treatment changes in postural orthostatic tachycardia syndrome

Impact of Comorbidities on the Prognosis of Pediatric Postural Tachycardia Syndrome

Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management

The Prevalence of Anxiety and Depression in Children With Postural Orthostatic Tachycardia Syndrome (POTS): A Retrospective Study

Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon

Clinical neurophysiology of postural tachycardia syndrome

Association of adolescent postural tachycardia syndrome classifications with anxiety: a cross sectional study

Correlates and predictors of symptom severity over time in people under investigation for postural orthostatic tachycardia syndrome (POTS)

The face of postural tachycardia syndrome – insights from a large cross‐sectional online community‐based survey

Postural tachycardia syndrome: a heterogeneous and multifactorial disorder

Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors

Symptom presentation by phenotype of postural orthostatic tachycardia syndrome

Navigating Complexity in Postural Orthostatic Tachycardia Syndrome

Autonomic dysfunction is prevalent in PASC of Covid-19 [PASC]

Impact of COVID-19 infection on baseline autonomic symptoms in patients with preexisting Postural Tachycardia Syndrome and Orthostatic Intolerance: A retrospective study

Postural Hyperventilation as a Cause of Postural Tachycardia Syndrome: Increased Systemic Vascular Resistance and Decreased Cardiac Output When Upright in All Postural Tachycardia Syndrome Variants

Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review

G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome

Orthostatic Hypertension in Children and Adolescents with Postural Tachycardia Syndrome

Dermatological Manifestations of Postural Tachycardia Syndrome Are Common and Diverse